2010
DOI: 10.3201/eid1607.091643
|View full text |Cite
|
Sign up to set email alerts
|

ACC-1 β-Lactamase–producingSalmonella entericaSerovar Typhi, India

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

2
32
0

Year Published

2013
2013
2022
2022

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 52 publications
(34 citation statements)
references
References 8 publications
2
32
0
Order By: Relevance
“…In the present study, 2% of S. enterica strains were observed to be resistant to third-generation cephalosporins (cefexime and ceftriaxone), similar to the proportions reported in a multi-centre Indian study and a report from Pakistan [9,35]. The recent reports of emerging extended spectrum beta lactamase-mediated resistance to ceftriaxone in S. Typhi and ACC-1 AmpC betalactamase producing S. Typhi strain conferring resistance to broad spectrum cephalosporins are alarming [36,37] as their spread among typhoidal salmonellae could seriously limit therapeutic options, and clinicians would likely have to resort to traditional first-line drugs or second line agents such as carbapenems and tigecycline.…”
Section: Discussionsupporting
confidence: 73%
“…In the present study, 2% of S. enterica strains were observed to be resistant to third-generation cephalosporins (cefexime and ceftriaxone), similar to the proportions reported in a multi-centre Indian study and a report from Pakistan [9,35]. The recent reports of emerging extended spectrum beta lactamase-mediated resistance to ceftriaxone in S. Typhi and ACC-1 AmpC betalactamase producing S. Typhi strain conferring resistance to broad spectrum cephalosporins are alarming [36,37] as their spread among typhoidal salmonellae could seriously limit therapeutic options, and clinicians would likely have to resort to traditional first-line drugs or second line agents such as carbapenems and tigecycline.…”
Section: Discussionsupporting
confidence: 73%
“…Most affected group was children less than 5 years of age as also documented by Mweu, et al and others [3,4,6]. Though there are previous reports of cephalosporin resistant Salmonella isolates from different parts of the world associated with its clinical failure [8][9][10][11][12][13], all the isolates in our study were fully susceptible to 3 rd gen cephalosporins and carbapenems. None of the Salmonella isolates were MDR.…”
Section: Discussionmentioning
confidence: 53%
“…Studies across the globe also documented an increase in number of quinolone resistant strains especially nalidixic acid resistant Salmonella typhi (NARST), apart from MDR isolates in typhoidal Salmonella [9][10][11][12][13]. Furthermore, various other studies across the globe documented an increase in resistance towards quinolones and third generation cephalosporins, commonly used for empirical treatment of enteric fever [8][9][10][11][12][13]. Azithromycin, a broad-spectrum macrolide antimicrobial, although costly, introduced later for the treatment of enteric fever, as a very good option because of its property of intra cellular concentration and good clinical response [14][15][16][17].…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…This indicates that there has been a situation to relook at the break points and the zone diameters for reporting ciprofloxacin resistance for Salmonella 17 . In the present study 4.7% of third generation cephalosporin resistant S.typhi have been isolated, which is a matter of concern 18 . We have screened for the ESBL producers among the third generation cephalosporin resistant strains by DDST phenotypic method.…”
Section: Discussionmentioning
confidence: 99%